PARD (Poniard Pharmaceuticals) Market Cap: $0.00 Mil (As of Jun. 24, 2026)


What is Poniard Pharmaceuticals Market Cap?

Poniard Pharmaceuticals PARD Market Cap is $0.00 Mil as of Jun. 24, 2026.

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Poniard Pharmaceuticals's share price for the quarter that ended in Sep. 2011 was $5. Poniard Pharmaceuticals's Shares Outstanding (EOP) for the quarter that ended in Sep. 2011 was 1.50 Mil. Therefore, Poniard Pharmaceuticals's market cap for the quarter that ended in Sep. 2011 was $7.50 Mil.

Poniard Pharmaceuticals's quarterly market cap declined from Mar. 2011 ($24.77 Mil) to Jun. 2011 ($13.76 Mil) and declined from Jun. 2011 ($13.76 Mil) to Sep. 2011 ($7.50 Mil).

Poniard Pharmaceuticals's annual market cap increased from Dec. 2008 ($66.93 Mil) to Dec. 2009 ($77.01 Mil) but then declined from Dec. 2009 ($77.01 Mil) to Dec. 2010 ($25.25 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Poniard Pharmaceuticals's Enterprise Value for Today is $0.00 Mil.

Poniard Pharmaceuticals  (OTCPK:PARD) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

Poniard Pharmaceuticals Market Cap Related Terms

Poniard Pharmaceuticals Market Cap Historical Data

* Premium members only.

The historical data trend for Poniard Pharmaceuticals's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Poniard Pharmaceuticals Market Cap Chart

Poniard Pharmaceuticals Annual Data
Trend Dec01 Dec02 Dec03 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 114.00 152.94 66.93 77.01 25.25

Poniard Pharmaceuticals Quarterly Data
Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 28.03 25.25 24.77 13.76 7.50

PARD vs OBMP, NSPX, ATRX: Market Cap Comparison

For the Biotechnology subindustry, Poniard Pharmaceuticals's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Poniard Pharmaceuticals Market Cap vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Poniard Pharmaceuticals's Market Cap distribution charts can be found below:

* The bar in red indicates where Poniard Pharmaceuticals's Market Cap falls into.


Poniard Pharmaceuticals Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Poniard Pharmaceuticals's Market Cap for the fiscal year that ended in Dec. 2010 is calculated as

Market Cap (A: Dec. 2010 )=Share Price (A: Dec. 2010 )*Shares Outstanding (EOP) (A: Dec. 2010 )
=$20.8*1.214
=$25.25

Poniard Pharmaceuticals's Market Cap for the quarter that ended in Sep. 2011 is calculated as

Market Cap (Q: Sep. 2011 )=Share Price (Q: Sep. 2011 )*Shares Outstanding (EOP) (Q: Sep. 2011 )
=$5*1.499
=$7.50

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Market Cap →
What does a Market Cap of $0.00 Mil mean?
Poniard Pharmaceuticals (PARD) has a Market Cap of $0.00 Mil as of Jun. 24, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Poniard Pharmaceuticals and its competitors.
Is Poniard Pharmaceuticals' Market Cap too high?
Poniard Pharmaceuticals' current Market Cap is $0.00 Mil.
How does Poniard Pharmaceuticals' Market Cap compare to OBMP and NSPX?
Poniard Pharmaceuticals' Market Cap of $0.00 Mil can be compared against companies in the Biotechnology industry. The industry median Market Cap is 117.26. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Biotechnology company?
The median Market Cap among Biotechnology companies is 117.26, based on 1,430 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Poniard Pharmaceuticals and its competitors. For the Biotechnology industry, the median Market Cap is 117.26 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Poniard Pharmaceuticals's current Market Cap is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Poniard Pharmaceuticals stock overvalued right now?
Poniard Pharmaceuticals (PARD) has a current Market Cap of $0.00 Mil. The current Market Cap is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Poniard Pharmaceuticals (PARD), the current Market Cap is $0.00 Mil as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Poniard Pharmaceuticals Business Description

Address 300 Elliott Avenue West, Suite 530, Seattle, CA, USA, 98119
Poniard Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of cancer therapeutics. Its product candidate is picoplatin, a new generation platinum-based cancer therapy.